Emtriva is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Emtricitabine.
Product ID | 70518-1847_8125e09e-a04f-4294-e053-2a91aa0a1835 |
NDC | 70518-1847 |
Product Type | Human Prescription Drug |
Proprietary Name | Emtriva |
Generic Name | Emtricitabine |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2019-02-04 |
Marketing Category | NDA / NDA |
Application Number | NDA021500 |
Labeler Name | REMEDYREPACK INC. |
Substance Name | EMTRICITABINE |
Active Ingredient Strength | 200 mg/1 |
Pharm Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-02-04 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021500 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-02-04 |
Ingredient | Strength |
---|---|
EMTRICITABINE | 200 mg/1 |
SPL SET ID: | bdee7e7a-688e-4171-a8cf-deefc42bfb04 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
46014-0601 | Emtriva | emtricitabine |
53808-0801 | Emtriva | emtricitabine |
61958-0601 | Emtriva | EMTRICITABINE |
61958-0602 | Emtriva | EMTRICITABINE |
70518-1847 | Emtriva | EMTRICITABINE |
69097-642 | emtricitabine | emtricitabine |
70518-2906 | emtricitabine | emtricitabine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EMTRIVA 78239710 2852092 Live/Registered |
Gilead Sciences, Inc. 2003-04-18 |